Targeted therapy is?a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
This report aims to provide a comprehensive presentation of the global market for Cancer Targeted Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Targeted Drug. This report contains market size and forecasts of Cancer Targeted Drug in global, including the following market information:
Global Cancer Targeted Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Targeted Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Sorafenib Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Targeted Drug include Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche and Bristol-Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Targeted Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Targeted Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Targeted Drug Market Segment Percentages, by Type, 2022 (%)
Sorafenib
Lenvatinib
Regorafenib
Osimertinib
Anlotinib
Alectinib
Other
Global Cancer Targeted Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Targeted Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Cancer Targeted Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Targeted Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Targeted Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Targeted Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Eisai
Zelgen
Cipla
Natco Pharma
AstraZeneca
Novartis
Roche
Bristol-Myers Squibb
Pfizer
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Targeted Drug, market overview.
Chapter 2: Global Cancer Targeted Drug market size in revenue.
Chapter 3: Detailed analysis of Cancer Targeted Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Targeted Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Targeted Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Targeted Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Targeted Drug Overall Market Size
2.1 Global Cancer Targeted Drug Market Size: 2022 VS 2029
2.2 Global Cancer Targeted Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Targeted Drug Players in Global Market
3.2 Top Global Cancer Targeted Drug Companies Ranked by Revenue
3.3 Global Cancer Targeted Drug Revenue by Companies
3.4 Top 3 and Top 5 Cancer Targeted Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Targeted Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Targeted Drug Players in Global Market
3.6.1 List of Global Tier 1 Cancer Targeted Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Targeted Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Targeted Drug Market Size Markets, 2022 & 2029
4.1.2 Sorafenib
4.1.3 Lenvatinib
4.1.4 Regorafenib
4.1.5 Osimertinib
4.1.6 Anlotinib
4.1.7 Alectinib
4.1.8 Other
4.2 By Type - Global Cancer Targeted Drug Revenue & Forecasts
4.2.1 By Type - Global Cancer Targeted Drug Revenue, 2018-2023
4.2.2 By Type - Global Cancer Targeted Drug Revenue, 2024-2029
4.2.3 By Type - Global Cancer Targeted Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Targeted Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Cancer Targeted Drug Revenue & Forecasts
5.2.1 By Application - Global Cancer Targeted Drug Revenue, 2018-2023
5.2.2 By Application - Global Cancer Targeted Drug Revenue, 2024-2029
5.2.3 By Application - Global Cancer Targeted Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Targeted Drug Market Size, 2022 & 2029
6.2 By Region - Global Cancer Targeted Drug Revenue & Forecasts
6.2.1 By Region - Global Cancer Targeted Drug Revenue, 2018-2023
6.2.2 By Region - Global Cancer Targeted Drug Revenue, 2024-2029
6.2.3 By Region - Global Cancer Targeted Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Targeted Drug Revenue, 2018-2029
6.3.2 US Cancer Targeted Drug Market Size, 2018-2029
6.3.3 Canada Cancer Targeted Drug Market Size, 2018-2029
6.3.4 Mexico Cancer Targeted Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Targeted Drug Revenue, 2018-2029
6.4.2 Germany Cancer Targeted Drug Market Size, 2018-2029
6.4.3 France Cancer Targeted Drug Market Size, 2018-2029
6.4.4 U.K. Cancer Targeted Drug Market Size, 2018-2029
6.4.5 Italy Cancer Targeted Drug Market Size, 2018-2029
6.4.6 Russia Cancer Targeted Drug Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Targeted Drug Market Size, 2018-2029
6.4.8 Benelux Cancer Targeted Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Targeted Drug Revenue, 2018-2029
6.5.2 China Cancer Targeted Drug Market Size, 2018-2029
6.5.3 Japan Cancer Targeted Drug Market Size, 2018-2029
6.5.4 South Korea Cancer Targeted Drug Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Targeted Drug Market Size, 2018-2029
6.5.6 India Cancer Targeted Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Targeted Drug Revenue, 2018-2029
6.6.2 Brazil Cancer Targeted Drug Market Size, 2018-2029
6.6.3 Argentina Cancer Targeted Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Targeted Drug Revenue, 2018-2029
6.7.2 Turkey Cancer Targeted Drug Market Size, 2018-2029
6.7.3 Israel Cancer Targeted Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Targeted Drug Market Size, 2018-2029
6.7.5 UAE Cancer Targeted Drug Market Size, 2018-2029
7 Cancer Targeted Drug Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Cancer Targeted Drug Major Product Offerings
7.1.4 Bayer Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Eisai
7.2.1 Eisai Company Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Cancer Targeted Drug Major Product Offerings
7.2.4 Eisai Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.2.5 Eisai Key News & Latest Developments
7.3 Zelgen
7.3.1 Zelgen Company Summary
7.3.2 Zelgen Business Overview
7.3.3 Zelgen Cancer Targeted Drug Major Product Offerings
7.3.4 Zelgen Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.3.5 Zelgen Key News & Latest Developments
7.4 Cipla
7.4.1 Cipla Company Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Cancer Targeted Drug Major Product Offerings
7.4.4 Cipla Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.4.5 Cipla Key News & Latest Developments
7.5 Natco Pharma
7.5.1 Natco Pharma Company Summary
7.5.2 Natco Pharma Business Overview
7.5.3 Natco Pharma Cancer Targeted Drug Major Product Offerings
7.5.4 Natco Pharma Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.5.5 Natco Pharma Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Cancer Targeted Drug Major Product Offerings
7.6.4 AstraZeneca Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Cancer Targeted Drug Major Product Offerings
7.7.4 Novartis Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Roche
7.8.1 Roche Company Summary
7.8.2 Roche Business Overview
7.8.3 Roche Cancer Targeted Drug Major Product Offerings
7.8.4 Roche Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.8.5 Roche Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Cancer Targeted Drug Major Product Offerings
7.9.4 Bristol-Myers Squibb Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Cancer Targeted Drug Major Product Offerings
7.10.4 Pfizer Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 BEACON Pharma
7.11.1 BEACON Pharma Company Summary
7.11.2 BEACON Pharma Business Overview
7.11.3 BEACON Pharma Cancer Targeted Drug Major Product Offerings
7.11.4 BEACON Pharma Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.11.5 BEACON Pharma Key News & Latest Developments
7.12 Jiangxi Shanxiang
7.12.1 Jiangxi Shanxiang Company Summary
7.12.2 Jiangxi Shanxiang Business Overview
7.12.3 Jiangxi Shanxiang Cancer Targeted Drug Major Product Offerings
7.12.4 Jiangxi Shanxiang Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.12.5 Jiangxi Shanxiang Key News & Latest Developments
7.13 Yao Pharma
7.13.1 Yao Pharma Company Summary
7.13.2 Yao Pharma Business Overview
7.13.3 Yao Pharma Cancer Targeted Drug Major Product Offerings
7.13.4 Yao Pharma Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.13.5 Yao Pharma Key News & Latest Developments
7.14 CSPC
7.14.1 CSPC Company Summary
7.14.2 CSPC Business Overview
7.14.3 CSPC Cancer Targeted Drug Major Product Offerings
7.14.4 CSPC Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.14.5 CSPC Key News & Latest Developments
7.15 CHIATAI Tianqing
7.15.1 CHIATAI Tianqing Company Summary
7.15.2 CHIATAI Tianqing Business Overview
7.15.3 CHIATAI Tianqing Cancer Targeted Drug Major Product Offerings
7.15.4 CHIATAI Tianqing Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.15.5 CHIATAI Tianqing Key News & Latest Developments
7.16 Simcere
7.16.1 Simcere Company Summary
7.16.2 Simcere Business Overview
7.16.3 Simcere Cancer Targeted Drug Major Product Offerings
7.16.4 Simcere Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.16.5 Simcere Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Targeted Drug Market Opportunities & Trends in Global Market
Table 2. Cancer Targeted Drug Market Drivers in Global Market
Table 3. Cancer Targeted Drug Market Restraints in Global Market
Table 4. Key Players of Cancer Targeted Drug in Global Market
Table 5. Top Cancer Targeted Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Targeted Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Targeted Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Targeted Drug Product Type
Table 9. List of Global Tier 1 Cancer Targeted Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Targeted Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Targeted Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Targeted Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Targeted Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Targeted Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Targeted Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Targeted Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Targeted Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Targeted Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Targeted Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Targeted Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Targeted Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Targeted Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Targeted Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Targeted Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Targeted Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Targeted Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Targeted Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Targeted Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Targeted Drug Revenue, (US$, Mn), 2024-2029
Table 30. Bayer Company Summary
Table 31. Bayer Cancer Targeted Drug Product Offerings
Table 32. Bayer Cancer Targeted Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer Key News & Latest Developments
Table 34. Eisai Company Summary
Table 35. Eisai Cancer Targeted Drug Product Offerings
Table 36. Eisai Cancer Targeted Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Eisai Key News & Latest Developments
Table 38. Zelgen Company Summary
Table 39. Zelgen Cancer Targeted Drug Product Offerings
Table 40. Zelgen Cancer Targeted Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Zelgen Key News & Latest Developments
Table 42. Cipla Company Summary
Table 43. Cipla Cancer Targeted Drug Product Offerings
Table 44. Cipla Cancer Targeted Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Cipla Key News & Latest Developments
Table 46. Natco Pharma Company Summary
Table 47. Natco Pharma Cancer Targeted Drug Product Offerings
Table 48. Natco Pharma Cancer Targeted Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Natco Pharma Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Cancer Targeted Drug Product Offerings
Table 52. AstraZeneca Cancer Targeted Drug Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Cancer Targeted Drug Product Offerings
Table 56. Novartis Cancer Targeted Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Roche Company Summary
Table 59. Roche Cancer Targeted Drug Product Offerings
Table 60. Roche Cancer Targeted Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Roche Key News & Latest Developments
Table 62. Bristol-Myers Squibb Company Summary
Table 63. Bristol-Myers Squibb Cancer Targeted Drug Product Offerings
Table 64. Bristol-Myers Squibb Cancer Targeted Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol-Myers Squibb Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Cancer Targeted Drug Product Offerings
Table 68. Pfizer Cancer Targeted Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. BEACON Pharma Company Summary
Table 71. BEACON Pharma Cancer Targeted Drug Product Offerings
Table 72. BEACON Pharma Cancer Targeted Drug Revenue (US$, Mn) & (2018-2023)
Table 73. BEACON Pharma Key News & Latest Developments
Table 74. Jiangxi Shanxiang Company Summary
Table 75. Jiangxi Shanxiang Cancer Targeted Drug Product Offerings
Table 76. Jiangxi Shanxiang Cancer Targeted Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Jiangxi Shanxiang Key News & Latest Developments
Table 78. Yao Pharma Company Summary
Table 79. Yao Pharma Cancer Targeted Drug Product Offerings
Table 80. Yao Pharma Cancer Targeted Drug Revenue (US$, Mn) & (2018-2023)
Table 81. Yao Pharma Key News & Latest Developments
Table 82. CSPC Company Summary
Table 83. CSPC Cancer Targeted Drug Product Offerings
Table 84. CSPC Cancer Targeted Drug Revenue (US$, Mn) & (2018-2023)
Table 85. CSPC Key News & Latest Developments
Table 86. CHIATAI Tianqing Company Summary
Table 87. CHIATAI Tianqing Cancer Targeted Drug Product Offerings
Table 88. CHIATAI Tianqing Cancer Targeted Drug Revenue (US$, Mn) & (2018-2023)
Table 89. CHIATAI Tianqing Key News & Latest Developments
Table 90. Simcere Company Summary
Table 91. Simcere Cancer Targeted Drug Product Offerings
Table 92. Simcere Cancer Targeted Drug Revenue (US$, Mn) & (2018-2023)
Table 93. Simcere Key News & Latest Developments
List of Figures
Figure 1. Cancer Targeted Drug Segment by Type in 2022
Figure 2. Cancer Targeted Drug Segment by Application in 2022
Figure 3. Global Cancer Targeted Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Targeted Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Targeted Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Targeted Drug Revenue in 2022
Figure 8. By Type - Global Cancer Targeted Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Targeted Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Targeted Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Targeted Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Targeted Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Targeted Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Targeted Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Targeted Drug Revenue Market Share, 2018-2029
Figure 16. US Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Targeted Drug Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Targeted Drug Revenue Market Share, 2018-2029
Figure 28. China Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Targeted Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Targeted Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Targeted Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Bayer Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eisai Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Zelgen Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cipla Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Natco Pharma Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Roche Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol-Myers Squibb Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Pfizer Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. BEACON Pharma Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Jiangxi Shanxiang Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Yao Pharma Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. CSPC Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. CHIATAI Tianqing Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Simcere Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
